Correction: ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation

Correction: ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538782/?tool=EBI

Similar Items

Correction: ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation.
by: Ryan H Kolb, et al.
Published: (2023-01-01)

ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes
by: Heeyoun Bunch, et al.
Published: (2023-12-01)

Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
by: Amol Mehta, et al.
Published: (2018-06-01)

The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
by: Bruno, Peter M, et al.
Published: (2021)

Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms
by: Jianfeng Shu, et al.
Published: (2024-04-01)

Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms
by: Jianfeng Shu, et al.
Published: (2023-08-01)

Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective
by: Ahmed M. Elshazly, et al.
Published: (2023-12-01)

Direct monitoring of the strand passage reaction of DNA topoisomerase II triggers checkpoint activation.
by: Katherine L Furniss, et al.
Published: (2013-01-01)

Correction: STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G2 Arrest in the Absence of DNA Damage
Published: (2013-01-01)

ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms
by: Jianfeng Shu, et al.
Published: (2023-01-01)

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases
Published: (2010-01-01)

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases.
by: Ivan Laponogov, et al.
Published: (2010-01-01)

Correction: Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases
Published: (2010-01-01)

SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatment
by: Junye Xie, et al.
Published: (2023-07-01)

Phosphorylation of the human topoisomerase II protein
by: Fry, A, et al.
Published: (1992)

Chromatinization modulates topoisomerase II processivity
by: Jaeyoon Lee, et al.
Published: (2023-10-01)

TSPYL2 is important for G1 checkpoint maintenance upon DNA damage.
by: Kin Pong Tao, et al.
Published: (2011-01-01)

The m<sup>7</sup>G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling
by: Jiancong Xie, et al.
Published: (2023-11-01)

Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma
by: Khaa Hoo Ong, et al.
Published: (2023-04-01)

The role of Topoisomerase II in replication in mammalian cells
by: Muftic, D
Published: (2011)

Targeting DNA Topoisomerase II in Antifungal Chemotherapy
by: Kavya Kondaka, et al.
Published: (2022-11-01)

The Roles of DNA Topoisomerase IIβ in Transcription
by: Ram Madabhushi
Published: (2018-06-01)

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade
by: Dipta Dey, et al.
Published: (2022-06-01)

Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation
by: Nicodemo Alexander A, et al.
Published: (2010-01-01)

MeCP2 represses the activity of topoisomerase IIβ in long neuronal genes
by: Sabin A. Nettles, et al.
Published: (2023-12-01)

Correction: Hesperidin Induces Paraptosis Like Cell Death in Hepatoblatoma, HepG2 Cells: Involvement of ERK1/2 MAPK
Published: (2014-01-01)

Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing
Published: (2024-04-01)

Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
by: Raymond W Wong, et al.
Published: (2024-04-01)

Facile Synthesis of Some Coumarin Derivatives and Their Cytotoxicity through VEGFR2 and Topoisomerase II Inhibition
by: Mohamed S. Gomaa, et al.
Published: (2022-11-01)

ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
by: Simon J. Cook, et al.
Published: (2022-07-01)

Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands
by: Madeleine Bossaert, et al.
Published: (2021-06-01)

G2/M checkpoint regulation and apoptosis facilitate the nuclear egress of parvoviral capsids
by: Salla Mattola, et al.
Published: (2022-12-01)

Infinitely many M2-instanton corrections to M-theory on G2-manifolds
by: Braun, A, et al.
Published: (2018)

Corrigendum: Pyruvate kinase M2 promotes prostate cancer metastasis through regulating ERK1/2-COX-2 signaling
by: Wenjing Guo, et al.
Published: (2024-02-01)

ERK/NF-kB/COX-2 Signaling Pathway Plays a Key Role in Curcumin Protection against Acetaminophen-Induced Liver Injury
by: An-Hsun Chou, et al.
Published: (2023-10-01)

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
by: Victor M. Matias-Barrios, et al.
Published: (2023-01-01)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
by: Caroline Molinaro, et al.
Published: (2020-10-01)

Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II
by: Beata Tylińska, et al.
Published: (2021-08-01)

Topoisomerase II of filarial parasite Setaria cervi: purification and characterization
by: Reddy J., et al.
Published: (2009-06-01)

GCNA Interacts with Spartan and Topoisomerase II to Regulate Genome Stability
by: Romer, Katherine A., et al.
Published: (2020)